Cillis J (2026). [PMID: 42075810](https://pubmed.ncbi.nlm.nih.gov/42075810/). *Pharmaceuticals (Basel)*. [Review / Meta-Analysis]
Pant S (2026). [PMID: 41460200](https://pubmed.ncbi.nlm.nih.gov/41460200/). *Clin Cancer Res*. [Clinical Trial Publication]
Qu R (2026). [PMID: 41686633](https://pubmed.ncbi.nlm.nih.gov/41686633/). *Medicine (Baltimore)*. [Diagnostic / Biomarker]
Sitthirak S (2026). [PMID: 41562920](https://pubmed.ncbi.nlm.nih.gov/41562920/). *Med Sci (Basel)*. [Review / Meta-Analysis]
Chiou LW (2026). [PMID: 41513002](https://pubmed.ncbi.nlm.nih.gov/41513002/). *Cell Mol Gastroenterol Hepatol*. [Basic Science / Preclinical]
Zhang J (2026). [PMID: 41939857](https://pubmed.ncbi.nlm.nih.gov/41939857/). *Front Immunol*. [Review / Meta-Analysis]
Ping R (2026). [PMID: 41959902](https://pubmed.ncbi.nlm.nih.gov/41959902/). *Front Oncol*. [Epidemiology / Natural History]
He F (2026). [PMID: 42090473](https://pubmed.ncbi.nlm.nih.gov/42090473/). *ACS Appl Mater Interfaces*. [Basic Science / Preclinical]
Rattaporn W (2026). [PMID: 41793671](https://pubmed.ncbi.nlm.nih.gov/41793671/). *Asian Pac J Cancer Prev*. [Epidemiology / Natural History]
Lin S (2026). [PMID: 42017899](https://pubmed.ncbi.nlm.nih.gov/42017899/). *Cancer Biomark*. [Epidemiology / Natural History]
